Send by Biomed Middle East

The patient began the pioneering treatment on Friday with an injection of the Geron Corporation's human embryonic stem cells, as part of a clinical trial [...]

Send by Los Angeles Times

The clinical trial, run by pharmaceutical company Geron Corp., seeks to test whether experimental cells, known as GRNOPC1, are safe for use in humans and [...]

Send by MedPage Today

Geron Corp. of Menlo Park, Calif., announced that a patient with a severe spinal cord injury under treatment at Shepherd Center in Atlanta is the first to [...]

Send by USA Today

It is one of of seven potential sites in the United States that may enroll patients in the clinical trial, according to the Geron Corp., which received [...]

Send by New York Daily News

A Geron spokeswoman did not return a call Monday. Seftel told the Daily News a German company, Xcell, is willing to treat Martinez with adult stem cells [...]

Send by Pharma Times

In what its chief executive called “a milestone for the field of human embryonic stem cell-based therapies”, Geron Corporation has finally launched a [...]

Send by The Associated Press

___ Geron tests stem cell treatment on patient NEW YORK (AP) — Geron Corp. has begun testing an embryonic stem-cell treatment on a patient with spinal cord [...]

Send by Reuters

Geron has the first US Food and Drug Administration license to use the controversial cells to treat people, in this case patients with new spinal cord [...]

Send by OneNewsNow

Geron Corp. issued a press release on Monday to the effect that it had injected millions of stem cells from human embryos -- derived from a process that [...]

Send by Commonweal (blog)

Reuters reports that Geron has launched a clinical trial of embryonic stem cells for treating spinal cord injury. It's a Phase I trial, that is, [...]

Send by MarketWatch

Geron Corp. (NASDAQ:GERN) shares were up 6% after it said it began a clinical study of a potential stem-cell treatment for spinal damage. Gymboree Corp. [...]

August 19, 2010 – The Motley Fool; 3 Stocks to Play BiotechAugust 09, 2010 – The Motley Fool; Back in Love With GeronAugust 02, 2010 – The Motley Fool [...]

2 Aug 2010 Almost a year after the FDA halted the study, Geron's clinical trial for a human embryonic stem cell (hESC) therapy for spinal cord injury [...]

25 Aug 2010 Geron is preparing to test the powerful cells in people with newly injured spinal cords for the very first time after getting a go-ahead [...]

See the company profile for Geron Corporation (GERN) including business summary, industry/sector information, number of employees, business summary, [...]

11 Oct 2010 WASHINGTON (Reuters) - US doctors have begun treating the first patient to receive human embryonic stem cells, but details of the landmark [...]

11 Oct 2010 First trial of human embryonic stem cells * Geron's product avoids federal funding limits * Geron shares up 4.1 pct in premarket trade (Adds [...]

11 Oct 2010 Geron Corp. has begun testing an embryonic stem-cell treatment on a patient with spinal cord injuries, marking the first time such a drug [...]

Send by fullmasti

Geron president Dr Thomas Okarma said: “When we started working with human embryonic stem cells in 1999, many predicted that it would be a number of decades before a cell therapy would be approved for human clinical trials. [...]

Geron Corp. has begun testing an embryonic stem-cell treatment on a patient with spinal cord injuries, marking the first time such a medical therapy has been used on a human in a government approved study. [...]

Send by samantha

A clinical trial using embryonic stem cells on patients with Grade A thoracic spinal cord injuries has enrolled its first patient, the Geron Corporation has. [...]

Send by Comtex Smartrend

Warner Chilcott (NASDAQ:WCRX) ranks first with a gain of 6.82%; Immunogen (NASDAQ:IMGN) ranks second with a gain of 5.92%; and Geron (NASDAQ:GERN) ranks [...]

Send by California Stem Cell Report

What they were talking about is Geron and its re-vitalized clinical trial of an hESC therapy for spinal injuries. The FDA late this week lifted its hold on the effort. Andy Pollack of the New York Times said "cysts were discovered in [...]

Send by BNO News

MENLO PARK, CALIFORNIA (BNO NEWS) -- Geron Corp. on Monday announced the enrollment of the first patient in the company's clinical trial of human embryonic stem cell (hESC)-derived oligodendrocyte progenitor cells, GRNOPC1. [...]

More than 500 protesters rallied against tuition fee hikes and budget cuts at the University of California at Berkeley today, including about 100 who planned to gather at the school's library well into the evening, a university spokeswoman said. Students at other UC and California State University s [...]